SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?


To: Thomas J Pittman who wrote (7831)11/25/1998 10:03:00 AM
From: aknahow  Respond to of 17367
 
From some post, not your last one Tom, one Could assume that it is a real benefit to make sure you can sue the company. If such a company tries to limit the ability of frivolous suits, they must be doing something wrong. Yes, in the last 50 years I have made lots of money thru shareholder suits. These suits have never cost any of the companies I owned stock in a dime.

Yep, one of the keys to value and profit is making sure you can sue the company after its' stock tanks. Must be a lot of people who share my belief. Who cares if Neuprex is approved. Might be better if it is not. Just think about the potential for making really big bucks by suing a company that will have few resources to defend against the suits.

Can't wait for the prospectus. Bet, I can find an error in it and perhaps we can even sue for that.

BTW stick a few of these wherever they belong or fit. <g> <g> <g>



To: Thomas J Pittman who wrote (7831)11/25/1998 10:55:00 AM
From: Bluegreen  Read Replies (1) | Respond to of 17367
 
I don't recall posting that I anticipated Xoma's move to Bermuda. I do, though, anticipate possible approval of Neuprex for Meningo. indication just like Xoma. But do I anticipate the possibility greatly enough to vote for move of domicile to Bermuda?